Lumexa Imaging forms joint venture with Hospital for Special Surgery

Lumexa Imaging (NASDAQ: LMRI) announced the formation of a joint venture with Hospital for Special Surgery to expand outpatient imaging services in the New York City metro area.

The collaboration represents Lumexa Imaging's ninth joint venture and aims to increase access to advanced outpatient imaging services across the region. The companies plan to bring imaging services closer to patients and referring providers in New York, which the press release describes as one of the nation's largest healthcare markets.

"Our collaboration with HSS represents an important milestone in Lumexa Imaging's continued growth," said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. "We are building a differentiated outpatient imaging platform by teaming up with leading health systems that share our commitment to clinical excellence, innovation, and patient-centered care."

Dr. Bryan T. Kelly, President and CEO of HSS, stated that "Lumexa Imaging stood out for its proven joint venture model, strong operational capabilities, and shared commitment to clinical excellence and patient access."

The joint venture supports Lumexa Imaging's strategy to expand through development, acquisitions, and partnerships with health systems. The companies indicated they are evaluating additional outpatient imaging locations across the region as part of long-term expansion plans.

Lumexa Imaging operates over 190 outpatient imaging centers with more than 5,000 team members and conducted approximately 4 million outpatient procedures system-wide in 2025, according to the press release. Hospital for Special Surgery is ranked as the top orthopedic hospital by U.S. News & World Report for 16 consecutive years.

You May Also Be Interested In

• Orion Digital receives Nasdaq minimum bid price deficiency notice
• Spyre Therapeutics (SYRE) files mixed shelf
• Hemab Therapeutics to present pipeline data at ISTH 2026